Análisis de anticuerpos antifosfolipídicos y cistatina C en pacientes con esclerosis múltiple

Arrobas Velilla, Teresa; García Sánchez, María Isabel; González Rodríguez, Concepción; Bermudo Guitarte, Carmen; Izquierdo Ayuso, Guillermo; Fabiani Romeroa, Fernando.
Acta bioquím. clín. latinoam ; 47(3): 523-528, set. 2013. tab
Artículo en Español | LILACS | ID: lil-694571

Documentos relacionados

  1. Imprecision remains to be improved in the measurement of serum cystatin C with heterogeneous systems.
  2. Optimal assessment of the glomerular filtration rate in older chinese patients using the equations of the Berlin Initiative Study.
  3. Extending the cystatin C based EKFC-equation to children - validation results from Europe.
  4. Development and Evaluation of Europium-Based Quantitative Lateral Flow Immunoassay for the Chronic Kidney Disease Marker Cystatin-C.
  5. The determination of cystatin C in biological samples via the surface plasmon resonance method.
  6. [Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies].
  7. [Conditional optimization and methodological evaluation of liquid protein microarray in detecting cystatin C].
  8. Recalibration of cystatin C using standardized material in Siemens nephelometers.
  9. [Did ketogenic diet in past centuries protect against the consequence of the cystatin L68Q mutation in carriers of HCCAA?]
  10. Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study.